Ratings M&A Research Institute Holdings Inc.

Equities

9552

JP3167370000

Delayed Japan Exchange 12:34:53 2024-06-06 am EDT 5-day change 1st Jan Change
3,775 JPY 0.00% Intraday chart for M&A Research Institute Holdings Inc. +0.53% -15.53%

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.

Weaknesses

  • With an expected P/E ratio at 41.19 and 23.98 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • Based on current prices, the company has particularly high valuation levels.
  • The company appears highly valued given the size of its balance sheet.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Investment Banking & Brokerage Services

1st Jan change Capi. Investor Rating ESG Refinitiv
-15.53% 1.42B -
-11.97% 26.92B
D+
-7.12% 15.61B
B
+3.39% 13.48B
C
+51.34% 13.44B
C-
-27.62% 10.35B
B
-7.82% 8.65B
B-
-16.18% 6.75B - -
+4.70% 5.79B
D+
-10.39% 5.35B
C
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 9552 Stock
  4. Ratings M&A Research Institute Holdings Inc.